Utility of the PFA-100 Instrument and the Novel Multiplate Analyzer for the Assessment of Aspirin and Clopidogrel Effects on Platelet Function in Patients With Cardiovascular Disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 6, 2009, Pages 652-659

  Mueller, Thomas ^a   Dieplinger, Benjamin ^a   Poelz, Werner ^b   Haltmayer, Meinhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

Author keywords

aggregometry; aspirin; cardiovascular disease; clopidogrel; drugs; platelets; thienopyridines

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; CLOPIDOGREL; COLLAGEN; DRUG DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR DISEASE; DRUG EFFECT; EVALUATION; FEMALE; HUMAN; IMPEDANCE; INSTRUMENTATION; MALE; MIDDLE AGED; PHOTOMETRY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE ACTIVATION;

ADENOSINE DIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR DISEASES; COLLAGEN; ELECTRIC IMPEDANCE; EPINEPHRINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; TICLOPIDINE;

EID: 75549085884     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608322547     Document Type: Article

References (20)

1. Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation. 2007; 115: 2196-2207.
2. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J. 2006; 27: 647-654.
3. Michelson AD, Frelinger AL 3rd, Furman MI Current options in platelet function testing. Am J Cardiol. 2006; 98(10A):4N-10N.
4. Campbell CL, Steinhubl SR Variability in response to aspirin: do we understand the clinical relevance? J Thromb Haemost. 2005; 3: 665-669.
5. Hankey GJ, Eikelboom JW Aspirin resistance. Lancet. 2006; 367: 606-617.
6. Wiviott SD Clopidogrel response variability, resistance, or both? Am J Cardiol. 2006; 98(10):18N-24N.
7. Gurbel PA, Tantry US Clopidogrel resistance? Thromb Res. 2007; 120: 311-321.
8. Harrison P., Frelinger AL 3rd, Furman MI, Michelson AD Measuring antoplatelet drug effects in the laboratory. Thromb Res. 2007; 120: 323-36.
9. Francis JL The platelet function analyzer (PFA)-100. In: Michelson AD, ed. Platelets. 2nd ed. San Diego, CA: Elsevier/Academic Press, 2006: 519-534.
10. Mueller T., Haltmayer M., Poelz W., Haidinger D. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease. Vasc Endovascular Surg. 2003; 37: 117-123.
11. Calatzis A., Wittwer M., Krueger B. A new approach to platelet function analysis in whole blood — the Multiplate analyzer. Platelets. 2004; 15: 485-486.
12. Tóth O., Calatzis A., Penz S., Losonczy H., Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost. 2006; 96: 781-788.
13. Mueller T., Dieplinger B., Poelz W., Calatzis A., Haltmayer M. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer — comparison with two flow cytometric methods. Thromb Res. 2007; 121: 249-258.
14. von Pape KW, Dzijan-Horn M., Bohner J., Spannagl M., Weisser H., Calatzis A. Control of aspirin effect in chronic cardiovascular patients using two whole blood platelet function assays. PFA-100 and Multiplate. Hämostaseologie. 2007; 27: 155-160.
15. Sibbing D., Braun S., Jawansky S., Vogt W., Mehilli J., Schömig A., Kastrati A., von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost. 2008; 99: 121-126.
16. Linnemann B., Rechner A., Schwonberg J., Mani H., Lindhoff-Last E. Assessment of clopidogrel non-response in patients with peripheral arterial disease (PAD) by the platelet function analyzer (PFA-100) using an experimental P2Y cartridge. Hämostaseologie. 2008; 28: A81.
17. Rechner A., Jakubowski JA, Sugidachi A., Oehler C., Zander N. The sensitivity of a new cartridge design for the PFA-100 system to inhibition of platelet function by the active metabolite of prasugrel (R-138727). Hämostaseologie. 2008; 28: A84.
18. Seyfert UT, Haubelt H., Vogt A., Hellstern P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets. 2007; 18: 199-206.
19. del Zoppo GJ Central nervous system ischemia. In: Michelson AD, ed. Platelets. 2nd ed. San Diego, CA: Elsevier/Academic Press, 2006: 657-683.
20. Stratmann B., Menart B., Tschoepe D. Diabetes mellitus. In: Michelson AD, ed. Platelets. 2nd ed. San Diego, CA: Elsevier/Academic Press, 2006: 697-711.